ERBB2 and breast carcinoma: As shown in Figure 4A&B and Table 2, patients with tumors of the luminal-like subtype had a better prognosis than those with basal-like breast cancer, a similar prognosis to those with ERBB2+, luminal B or claudin-low tumors, but a worse prognosis than patients with luminal A and normal-like breast tumors.